Fallopian Tube Cancer

Common Name(s)

Fallopian Tube Cancer

Fallopian tube cancer is a very rare form of cancer with only 1,500 to 2,000 cases reported each year in the United States. However, a number of cancers start in other parts of the body and spread to the fallopian tubes, called secondary fallopian tube cancers. Some symptoms include abnormal vaginal bleeding, abnormal vaginal discharge, abdominal pain, and feeling a mass in the abdomen (belly) or pelvis. A female pelvic exam can assist in the diagnosis of this condition by evaluating the size and shape of the uterus, vagina, ovaries, fallopian tubes, bladder and rectum. A blood test can also be performed to check the levels of a certain protein called CA125, which may be used to diagnose fallopian tube cancer. Treatment usually involves surgery and chemotherapy, depending on age, desire to have children, and the type and stage of the tumor.

Source: Advocacy organizations associated with the condition.

Jump to Topic
Advocacy and Support Organizations Health Questions Recommended Apps Scientific Literature Symptoms, Diagnosis, and Treatment Clinical Trial Information
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fallopian Tube Cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

Recommended Apps

Privately answer questions about your health. Let resources, you select, come to you

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

Learn More
Relief is when you and the right researcher find each other

Finding the right clinical trial for Fallopian Tube Cancer can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.

Learn More
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Fallopian Tube Cancer" returned 71 free, full-text research articles on human participants. First 3 results:

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
 

Author(s): Junzheng Yang, Yilan Zhou, Shu-Kay Ng, Kuan-Chun Huang, Xiaoyan Ni, Pui-Wah Choi, Kathleen Hasselblatt, Michael G Muto, William R Welch, Ross S Berkowitz, Shu-Wing Ng

Journal:

 

Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if ...

Last Updated: 31 Dec 1969

Go To URL
Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
 

Author(s): Na-Yiyuan Wu, Hsuan-Shun Huang, Tung Hui Chao, Hsien Ming Chou, Chao Fang, Chong-Zhen Qin, Chueh-Yu Lin, Tang-Yuan Chu, Hong Hao Zhou

Journal: Cell Rep. 2017 03;18(11):2557-2565.

 

High-grade serous ovarian carcinoma (HGSOC) originates mainly from the fallopian tube (FT) epithelium and always carries early TP53 mutations. We previously reported that tumors initiate in the FT fimbria epithelium because of apoptotic failure and the expansion of cells with DNA ...

Last Updated: 31 Dec 1969

Go To URL
Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
 

Author(s): Matthew Dean, David A Davis, Joanna E Burdette

Journal: Cancer Lett.. 2017 04;391():114-124.

 

Factors that stimulate the migration of fallopian tube epithelial (FTE)-derived high-grade serous ovarian cancer (HGSOC) to the ovary are poorly elucidated. This study characterized the effect of the ovarian hormone, activin A, on normal FTE and HGSOC. Activin A and TGFβ1 induced ...

Last Updated: 31 Dec 1969

Go To URL

To view other free, full-text articles on human participants, please click on the link below.

PubMed Article Results at NCBI: 71 article(s)

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Fallopian Tube Cancer" returned 7 free, full-text review articles on human participants. First 3 results:

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
 

Author(s): W Glenn McCluggage, Meagan J Judge, Blaise A Clarke, Ben Davidson, C Blake Gilks, Harry Hollema, Jonathan A Ledermann, Xavier Matias-Guiu, Yoshiki Mikami, Colin J R Stewart, Russell Vang, Lynn Hirschowitz,

Journal: Mod. Pathol.. 2015 Aug;28(8):1101-22.

 

A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the ...

Last Updated: 31 Dec 1969

Go To URL
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
 

Author(s): Jaime Prat,

Journal: J Gynecol Oncol. 2015 Apr;26(2):87-9.

 

Last Updated: 31 Dec 1969

Go To URL
Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update.
 

Author(s): Felix Zeppernick, Ivo Meinhold-Heerlein, Ie-Ming Shih

Journal: J. Obstet. Gynaecol. Res.. 2015 Jan;41(1):6-11.

 

Ovarian tumors comprise a wide variety of entities. The largest group, epithelial ovarian carcinoma, can be classified into two main groups, type I and type II tumors. Recent advances in the understanding of ovarian cancer development have resulted in the finding of 'serous tubal ...

Last Updated: 31 Dec 1969

Go To URL

To view other free, full-text review articles on human participants, please click on the link below.

PubMed Review Results at NCBI: 7 review(s)

 
 
Top

Symptoms, Diagnosis, and Treatment

This information is provided by Genetics Home Reference.
https://ghr.nlm.nih.gov/condition/persistent-mullerian-duct-syndrome
https://ghr.nlm.nih.gov/condition/ovarian-cancer
https://ghr.nlm.nih.gov/gene/AMH
https://ghr.nlm.nih.gov/gene/AMHR2
https://ghr.nlm.nih.gov/condition/swyer-syndrome
https://ghr.nlm.nih.gov/gene/SRY
https://ghr.nlm.nih.gov/condition/lung-cancer
https://ghr.nlm.nih.gov/condition/bladder-cancer
https://ghr.nlm.nih.gov/condition/breast-cancer
https://ghr.nlm.nih.gov/condition/prostate-cancer
https://ghr.nlm.nih.gov/condition/parathyroid-cancer
https://ghr.nlm.nih.gov/gene/DHH
https://ghr.nlm.nih.gov/gene/MAP3K1
https://ghr.nlm.nih.gov/gene/TBXT
https://ghr.nlm.nih.gov/gene/FGFR4
https://ghr.nlm.nih.gov/gene/MTHFR
https://ghr.nlm.nih.gov/condition/mullerian-aplasia-and-hyperandrogenism
https://ghr.nlm.nih.gov/gene/NR5A1
https://ghr.nlm.nih.gov/condition/lynch-syndrome
https://ghr.nlm.nih.gov/condition/hereditary-diffuse-gastric-cancer
Full Results at Genetics Home Reference: 687 matches

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Trial of Carboplatin-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel-Bevacizumab-Rucaparib vs Carboplatin-Paclitaxel-Rucaparib in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer.
 

Status: Recruiting

Condition Summary: Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer

 

Last Updated: 9 Mar 2018

Go to URL
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
 

Status: Not yet recruiting

Condition Summary: Ovarian Epithelial Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

 

Last Updated: 30 Apr 2015

Go to URL
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
 

Status: Recruiting

Condition Summary: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer

 

Last Updated: 13 Feb 2018

Go to URL
According to ClinicalTrials.gov there are currently 138 additional "open" studies for "Fallopian Tube Cancer" (open studies are recruiting volunteers) and 617 "Fallopian Tube Cancer" studies with "all" status. Visit ClinicalTrials.gov now to view them. Or alternatively, consider TrialsFinder for assistance:
TrialsFinder Branding Graphics
Relief is when you and the right researcher find each other
Finding the right clinical trial for Fallopian Tube Cancer can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.
Learn More